Host vascular endothelial growth factor is trophic for Plasmodium falciparum-infected red blood cells

Asian Pacific Journal of Allergy and Immunology

Volumn 26, Issue 1, 2008, Pages 37-45

  Sachanonta, Navakanit ^a   Medana, Isabelle M ^b   Roberts, Rachel ^b   Jones, Margaret ^b   Day, Nicholas P J ^a   White, Nicholas J ^a   Ferguson, David J P ^b   Turner, Gareth D H ^a,b   Pongponratn, Emsri ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER; QUININE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADULT; ARTICLE; AUTOPSY; BRAIN BLOOD VESSEL; BRAIN MALARIA; CELL CULTURE; CELL VACUOLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE SEVERITY; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; HOST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIFE CYCLE; MALARIA FALCIPARUM; MICROVASCULATURE; NONHUMAN; PARASITE DEVELOPMENT; PATHOGENESIS; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR UPREGULATION; VIET NAM;

ANIMALS; ANTIMALARIALS; ARTEMISININS; CELLS, CULTURED; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MALARIA, FALCIPARUM; MICROSCOPY, CONFOCAL; PLASMODIUM FALCIPARUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 45349106897     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. World Health Organization. Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000; 94: S1-S90.
2. Breman JG. The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. Am J Trop Med Hyg 2001; 64: 1-11.
3. Idro R, Jenkins NE, Newton CR. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol 2005; 4: 827-40.
4. Turner G. Cerebral malaria. Brain Pathol 1997; 7: 569-82.
5. Ho M, White NJ. Molecular mechanisms of cytoadherence in malaria. Am J Physiol 1999; 276: C1231-42.
6. Silamut K, Phu NH, Whitty C, et al. A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. Am J Pathol 1999; 155: 395-410.
7. Pongponratn E, Turner GD, Day NP, et al. An ultrastructural study of the brain in fatal Plasmodium falciparum malaria. Am J Trop Med Hyg 2003; 69: 345-59.
8. Medana IM, Turner GD. Human cerebral malaria and the blood-brain barrier. Int J Parasitol 2006; 36: 555-68.
9. Idro R, Ndiritu M, Ogutu B, et al. Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan children. Jama 2007; 297: 2232-40.
10. Tripathi AK, Sullivan DJ, Stins MF. Plasmodium falciparum-infected erythrocytes decrease the integrity of human blood-brain barrier endothelial cell monolayers. J Infect Dis 2007; 195: 942-50.
11. Jenkins N, Wu Y, Chakravorty S, Kai O, Marsh K, Craig A. Plasmodium falciparum intercellular adhesion molecule-1-based cytoadherence-related signaling in human endothelial cells. J Infect Dis 2007; 196: 321-7.
12. Susomboon P, Maneerat Y, Dekumyoy P, et al. Down-regulation of tight junction mRNAs in human endothelial cells co-cultured with Plasmodium falciparum-infected erythrocytes. Parasitol Int 2006; 55: 107-12.
13. Cordery DV, Kishore U, Kyes S, et al. Characterization of a Plasmodium falciparum macrophage-migration inhibitory factor homologue. J Infect Dis 2007; 195: 905-12.
14. Medana IM, Mai NT, Day NP, et al. Cellular stress and injury responses in the brains of adult Vietnamese patients with fatal Plasmodium falciparum malaria. Neuropathol Appl Neurobiol 2001; 27: 421-33.
15. Medana IM, Day NP, Hien TT, et al. Axonal injury in cerebral malaria. Am J Pathol 2002; 160: 655-66.
16. Ratcliffe PJ, O'Rourke JF, Maxwell PH, Pugh CW. Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. J Exp Biol 1998; 201: 1153-62.
17. Harris AL. Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2: 38-47.
18. Maxwell PH, Pugh CW, Ratcliffe PJ. Inducible operation of the erythropoietin 3′ enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism. Proc Natl Acad Sci USA 1993; 90: 2423-7.
19. Talks KL, Turley H, Gatter KC, et al. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 2000; 157: 411-21.
20. Robinson CJ, Stringer SE. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci 2001; 114: 853-65.
21. Otrock ZK, Makarem JA, Shamseddine AI. Vascular endothelial growth factor family of ligands and receptors: review. Blood Cells Mol Dis 2007; 38: 258-68.
22. Maharaj AS, D'Amore PA. Roles for VEGF in the adult. Microvasc Res 2007; 74: 100-13.
23. Deininger MH, Winkler S, Kremsner PG, Meyermann R, Schluesener HJ. Angiogenic proteins in brains of patients who died with cerebral malaria. J Neuroimmunol 2003; 142: 101-11.
24. Tran TH, Day NP, Nguyen HP, et al. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med 1996; 335: 76-83.
25. Kyes S, Craig A, Marsh K, Newbold C. Plasmodium falciparum: a method for the amplification of S antigens and its application to laboratory and field samples. Exp Parasitol 1993; 77: 473-83.
26. Stewart M, Turley H, Cook N, et al. The angiogenic receptor KDR is widely distributed in human tissues and tumours and relocates intracellularly on phosphorylation. An immunohistochemical study. Histopathology 2003; 43: 33-9.
27. Turley H, Scott PA, Watts VM, Bicknell R, Harris AL, Gatter KC. Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1. J Pathol 1998; 186: 313-8.
28. Norton A, Jordan S, Yeohans P. Brief, high temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues. J Pathol 1994; 173: 371-9.
29. Trager W, Jensen JB. Human malaria parasites in continuous culture. Science 1976; 193: 673-5.
30. Roberts D, Craig A, Berendt A, et al. Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature 1992; 357: 689-92.
31. Rogerson SJ, Katundu P, Molyneux ME. Rosette formation by clinical isolates of Plasmodium falciparum in serum-free medium. Trans R Soc Trop Med Hyg 2000; 94: 461-2.
32. Banks RE, Forbes MA, Kinsey SE, et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 1998; 77: 956-64.
33. Kirk K, Martin RE, Broer S, Howitt SM, Saliba KJ. Plasmodium permeomics: membrane transport proteins in the malaria parasite. Curr Top Microbiol Immunol 2005; 295: 325-56.
34. Murphy SC, Hiller NL, Harrison T, Lomasney JW, Mohandas N, Haldar K. Lipid rafts and malaria parasite infection of erythrocytes. Mol Membr Biol 2006; 23: 81-8.
35. Lyttle DJ, Fraser KM, Fleming SB, Mercer AA, Robinson AJ. Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus. J Virol 1994; 68: 84-92.
36. Savory LJ, Stacker SA, Fleming SB, Niven BE, Mercer AA. Viral vascular endothelial growth factor plays a critical role in orf virus infection. J Virol 2000; 74: 10699-706.
37. Lu M, Perez VL, Ma N, et al. VEGF increases retinal vascular ICAM-1 expression in vivo. Invest Ophthalmol Vis Sci 1999; 40: 1808-12.
38. Dobrogowska DH, Lossinsky AS, Tarnawski M, Vorbrodt AW. Increased blood-brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor. J Neurocytol 1998; 27: 163-73.
39. Fischer S, Wobben M, Marti HH, Renz D, Schaper W. Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc Res 2002; 63: 70-80.
40. Brown H, Hien TT, Day N, et al. Evidence of blood-brain barrier dysfunction in human cerebral malaria. Neuropathol Appl Neurobiol 1999; 25: 331-40.
41. Zachary I. Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential. Neurosignals 2005; 14: 207-21.